期刊文献+

复方嗜酸乳杆菌片联合蒙脱石散治疗婴幼儿肺炎抗生素相关性腹泻的临床研究 被引量:35

Clinical observation of Montmorillonite combined with Compound Eosinophil-Lactobacillus Tablet in treatment of pneumonia infants of antibiotic associated diarrhea
原文传递
导出
摘要 目的探讨复方嗜酸乳杆菌片联合蒙脱石散治疗婴幼儿肺炎抗生素相关性腹泻(antibiotic associated diarrhea,AAD)的疗效。方法选取80例AAD患儿,按随机数字表法分为两组,对照组(39例)口服蒙脱石散,观察组(41例)给予蒙脱石散联合嗜酸乳杆菌片,观察并记录两组患者治疗后的疗效,临床症状缓解情况,免疫功能变化及治疗期间不良反应发生情况,评价复方嗜酸乳杆菌片联合蒙脱石散治疗AAD的疗效。结果治疗后观察组有效率明显高于对照组(P<0.05)。治疗后,观察组退热时间、纠正脱水时间、止泻时间均明显短于对照组(P<0.05);治疗后,观察组血清免疫球蛋白IgG、IgA水平均明显上升(P<0.05),T淋巴细胞亚群CD_3^+、CD_4^+水平均明显上升(P<0.05),相比之下,对照组治疗前后血清免疫球蛋白和T淋巴细胞亚群无明显变化。治疗期间,两组均无明显不良反应发生。结论复方嗜酸乳杆菌片联合蒙脱石散对AAD具有较好的治疗效果,能迅速改善腹泻症状,提高小儿体内免疫球蛋白水平,值得临床推广使用。 Objective To discuss the clinical observation of Montmorillonite combined with Compound Eosinophil-Lactobacillus Tablet in the treatment of pneumonia infants of antibiotic associated diarrhea (AAD). Methods Eighty pneumonia infants with antibiotic associated diarrhea were selected, they were divided into two groups according to the random number table method. The observation group (41 cases) was given Montmorillonite. The control group (39 cases) was given Montmorillonite and Compound Eosinophil-Lactobacillus. The efficacy of Montmorillonite combined with compound Eosinophil-Lactobacillus Tablet in the treatment of pneumonia infants of antibiotic associated diarrhea was evaluated by efficacy, clinical symptom, immune function changes and adverse reactions during the treatment period. Results After treatment, the effective rate of observation group was higher than that of the control group (P 〈 0.05). After treatment, the fever time, correcting dehydration time, and antidiarrheal time of observation group was shorter than that of the control group (P 〈 0.05). After treatment, the serum IgG, IgA, and T lymphocyte subsets of CD3+, CD4+ levels were significantly increased in the observation group (P 〈 0.05). There was no statistical significance on CD8+ before and after treatment. In contrast, there were no statistical significance on the serum immunoglobulin and T lymphocyte subsets before and aider treatment in the control group. During the treatment period, no adverse reaction occurred in two groups. Conclusion In summary, Montmorillonite combined with Compound Eosinophil-Lactobacillus Tablet had a good effect on AAD. They could quickly improve the symptoms of diarrhea and immunoglobulin levels in children. It was worthy of clinical use.
作者 袁雪 陈玺
出处 《药物评价研究》 CAS 2017年第1期83-86,共4页 Drug Evaluation Research
关键词 蒙脱石散 复方嗜酸乳杆菌片 抗生素相关性腹泻 疗效 不良反应 Montmorillonite Compound Eosinophil-Lactobacillus Tablet antibiotic associated diarrhea efficacy adverse reaction
  • 相关文献

参考文献4

二级参考文献23

  • 1培菲康防治婴幼儿肺炎继发腹泻协作组.培菲康预防婴幼儿肺炎继发腹泻随机、多中心临床研究[J].临床儿科杂志,2006,24(10):848-849. 被引量:34
  • 2陈永红,王镭,王云亭.儿科疾病与疗效标准[M].上海:上海中医药大学出版社.2006:47-49.
  • 3胡亚美 江载芳.诸福棠实用儿科学[M]第7版[M].北京:人民卫生出版社,2002.1514.
  • 4LYRAS D,O'CONNOR J R, HOWARTH P M, et al. Toxin B is essential for virulence of Clostridium diffi- cile[J]. Nature, 2009,458 1176-- 1179.
  • 5MULLAN N, HUGHES K R, MAHIDA Y R. Primary human colonic myofibroblasts are resistant to Clostrid- ium difficile toxin A-induced, but nottoxin B-induced, cell death[J]. Infect Immun, 2011,79 : 1623-- 1630.
  • 6Vaishnavi C, Kaur S, Singh K. Clostridium perfringens type A & antibi- otic associated diarrhea[ J]. Indian J Med Res, 2005,122(1) :52.
  • 7Correa NB, Penna FJ, Lima FM, et al. Treatment of acute diarrhea with saccharomyces bottlardii in infants [J]. J Pediatr Gastroenterol Nutr, 2011,53(5) : 497.
  • 8Riaz M,Alam S, Malik A, et al. Efficacy and safety of Saccharomyces boulardii in acute childhood diarrhea: a double blind randomised con- trolled trial[J]. Indian J Pediatr,2012,79(4):478.
  • 9刘保良,陈玮.抗生素相关性腹泻及其预防治疗[J].临床合理用药杂志,2008,1(1):51-53. 被引量:23
  • 10岳玉国.肠道微生态与儿童营养、免疫和益生元[J].国外医学(儿科学分册),1998,25(3):143-145. 被引量:32

共引文献41

同被引文献289

引证文献35

二级引证文献271

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部